Ophthalmic Antiglaucoma Agents

Ophthalmic antiglaucoma agents are a broad therapeutic class of ocular medications formulated to reduce intraocular pressure and prevent progressive optic nerve damage and vision loss

Ophthalmic antiglaucoma agents are a broad therapeutic class of ocular medications formulated to reduce intraocular pressure and prevent progressive optic nerve damage and vision loss These agents achieve ocular hypotension primarily by decreasing aqueous humor production, increasing trabecular or uveoscleral outflow, or combining both pathways through mechanisms that include prostaglandin analogues, beta-adrenergic antagonists, alpha-2 adrenergic agonists, carbonic anhydrase inhibitors, and Rho...

These agents achieve ocular hypotension primarily by decreasing aqueous humor production, increasing trabecular or uveoscleral outflow, or combining both pathways through mechanisms that include prostaglandin analogues, beta-adrenergic antagonists, alpha-2 adrenergic agonists, carbonic anhydrase inhibitors, and Rho kinase inhibitors

They serve as the primary pharmacologic therapy for managing open-angle glaucoma, ocular hypertension, and select secondary glaucomas, as well as adjunctive medical stabilization in angle-closure glaucoma

They serve as the primary pharmacologic therapy for managing open-angle glaucoma, ocular hypertension, and select secondary glaucomas, as well as adjunctive medical stabilization in angle-closure glaucoma

They serve as the primary pharmacologic therapy for managing open-angle glaucoma, ocular hypertension, and select secondary glaucomas, as well as adjunctive medical stabilization in angle-closure glaucoma